Investors NYSE AMERICAN: LCTX Minimum 15 minutes delayed. Source: LSEG VIEW STOCK QUOTE Press Releases November 21, 2024 Lineage Cell Therapeutics Announces First Closing of up to $66 Million Registered Direct Offering November 20, 2024 Lineage Cell Therapeutics Announces Pricing of up to $66 Million Registered Direct Offering November 14, 2024 Lineage Cell Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update VIEW PRESS RELEASES Events & Presentations Roche Pharma Day 2024 Presentation 8.9 MB Lineage Cell Therapeutics Corporate Overview August 8, 2024 5.3 MB 2024 Retinal Cell & Gene Therapy Innovation Summit Presentation 1.6 MB Third Quarter 2024 Financial Results Earnings Call Nov 14, 2024 at 4:30 PM EST Click here for webcast VIEW EVENTS & PRESENTATIONS
November 21, 2024 Lineage Cell Therapeutics Announces First Closing of up to $66 Million Registered Direct Offering
November 20, 2024 Lineage Cell Therapeutics Announces Pricing of up to $66 Million Registered Direct Offering
November 14, 2024 Lineage Cell Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
Third Quarter 2024 Financial Results Earnings Call Nov 14, 2024 at 4:30 PM EST Click here for webcast